Which of the following statements by a client who is at 8 weeks of gestation and is Rh-negative indicates an understanding of the teaching about the Rho(D) immune globulin injection?
I will need this injection if I have a miscarriage.
I will need this injection when I am 12 weeks pregnant.
I will need this injection to prevent preterm labor.
I will need this injection after delivery if my baby is Rh-negative.
The Correct Answer is A
Choice A reason: Rho(D) immune globulin is administered after a miscarriage in Rh-negative women to prevent isoimmunization, as fetal blood mixing can occur. This immunoglobulin neutralizes Rh-positive fetal antigens, preventing maternal antibody formation that could affect future pregnancies. The immune response could otherwise lead to hemolytic disease in subsequent Rh-positive fetuses.
Choice B reason: Administering Rho(D) immune globulin at 12 weeks is not standard practice. It is typically given at 28 weeks and post-delivery or after events like miscarriage. Early administration is unnecessary unless a sensitizing event occurs, as maternal-fetal blood mixing is rare before the third trimester, per immunological principles.
Choice C reason: Rho(D) immune globulin does not prevent preterm labor, which is driven by uterine or hormonal factors. The injection targets Rh isoimmunization by neutralizing Rh-positive fetal antigens. Preterm labor involves prostaglandin and oxytocin pathways, unrelated to Rh sensitization, making this statement irrelevant to the immunoglobulin’s immunological mechanism.
Choice D reason: Rho(D) immune globulin is unnecessary post-delivery if the baby is Rh-negative, as no sensitization occurs without Rh-positive fetal blood. The injection is given only if the baby is Rh-positive to prevent maternal antibody formation. This statement reflects a misunderstanding of Rh immunology and isoimmunization risk in pregnancy.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is B
Explanation
Choice A reason: Bladder distention indicates an adverse effect of epidural analgesia, as nerve blockade impairs bladder sensation, leading to retention. This is not a sign of effective pain relief but a complication requiring monitoring or catheterization to prevent urinary tract infections or bladder overdistension, per epidural side effect management.
Choice B reason: Reporting slight pressure with contractions indicates effective epidural analgesia, as it reduces pain while preserving some sensation, allowing awareness of labor progress. This reflects targeted nerve blockade, alleviating visceral pain via opioid and anesthetic action, aligning with the goal of balanced labor analgesia without complete sensory loss.
Choice C reason: Inability to move legs or feet suggests excessive epidural blockade, a complication rather than effective analgesia. Optimal epidurals provide pain relief with minimal motor impairment, allowing mobility. Complete paralysis risks prolonged recovery or injury, not reflecting the therapeutic goal of labor pain management, per anesthesia protocols.
Choice D reason: A 20 mm Hg systolic blood pressure decrease indicates hypotension, an adverse effect of epidural analgesia due to sympathetic blockade. This risks reduced placental perfusion, not effective pain relief. It requires intervention like fluids, contrary to the goal of stable analgesia with minimal maternal or fetal impact.
Correct Answer is D
Explanation
Choice A reason: Stating that rubella vaccination prevents breastfeeding is incorrect. The rubella vaccine, a live-attenuated virus, is safe for postpartum administration in non-immune mothers, as it does not significantly excrete in breast milk or harm the infant. Breastfeeding supports neonatal immunity through maternal antibodies, and this statement misrepresents vaccine safety and breastfeeding physiology.
Choice B reason: Repeating a rubella titer in the third trimester is unnecessary unless new exposure is suspected. A titer of 1:8 indicates susceptibility, requiring postpartum immunization, not repeated testing. Serological testing monitors antibody levels, but rubella immunity status typically remains stable during pregnancy unless infection occurs, making routine retesting scientifically unjustified in this context.
Choice C reason: Administering rubella immunization during pregnancy is contraindicated, as it is a live vaccine that poses a theoretical risk to the fetus. A titer of 1:8 indicates susceptibility, warranting postpartum vaccination. The immune system’s response to live vaccines could potentially cross the placenta, affecting fetal development, so immunization is deferred until after delivery.
Choice D reason: A rubella titer of 1:8 indicates susceptibility, as titers below 1:10 suggest insufficient antibodies to confer immunity. Rubella infection during pregnancy can cause congenital rubella syndrome, leading to fetal anomalies. This statement accurately reflects the need for postpartum immunization to protect future pregnancies, aligning with serological evidence and prenatal care guidelines.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.